| | | |   | | | | By Mohana Ravindranath Adobe As new digital pharmacy companies crop up, here's what we know — and still don't know — about telehealth prescribing. Read More | | By Nicholas Florko Adobe Lawmakers are set to unveil draft legislation that will reform the FDA’s regulation of dietary supplements and cosmetics, sources told STAT. Read More | | By Ed Silverman Alex Hogan/STAT From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry. Read More | | Sponsor content by SANOFI AND REGENERON Making the type 2 inflammation connection between upper and lower respiratory diseases Type 2 inflammation, which contributes to most moderate-to-severe asthma cases, can also be involved in upper respiratory tract diseases like chronic rhinosinusitis with nasal polyposis. These diseases are often treated with immunosuppressants that don't specifically address their root causes and can be challenging to use long term. Learn about Sanofi and Regeneron's work in type 2 inflammation and the latest research in respiratory diseases at the American Thoracic Society (ATS) Annual Meeting (May 13-18). | | By Bob Herman Adobe New data provide a fresh look into the world of REITs — which essentially act as landlords to hospitals, nursing homes, and other providers. Read More | |
No comments